Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention.
OBJECTIVE
We examined whether anxiety has incremental value to depressive symptoms in predicting health status in patients undergoing percutaneous coronary intervention (PCI) treated in the drug-eluting stent era.


METHODS
A series of consecutive patients (n=692) undergoing PCI as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital registry completed the Hospital Anxiety and Depression Scale at 6 months and the Short-Form Health Survey (SF-36) at 6 and 12 months post-PCI.


RESULTS
Of 692 patients, 471 (68.1%) had no symptoms of anxiety nor depression, 62 (9.0%) had anxiety only, 59 (8.5%) had depressive symptoms only, and 100 (14.5%) had co-occurring symptoms. There was an overall significant improvement in health status between 6 and 12 months post-PCI (P<.001); the interaction effect for time by psychological symptoms was also significant (P=.003). Generally, patients with co-occurring symptoms reported significantly poorer health status compared with the other three groups (Ps <.001). Patients with co-occurring symptomatology were also at greater risk of impaired health status on six of the eight subdomains of the SF-36 compared with the other three symptom groups, adjusting for baseline characteristics and health status at 6 months.


CONCLUSIONS
Patients with co-occurring symptoms of anxiety and depression reported poorer health status compared with anxious or depressed-only patients and no-symptom patients, showing that anxiety has incremental value to depressive symptoms in identifying PCI patients at risk for impaired health status treated in the drug-eluting stent era.
Pedersen
Susanne S
SS
Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands. s.s.pedersen@uvt.nl
Denollet
Johan
J
Spindler
Helle
H
Ong
Andrew T L
AT
Serruys
Patrick W
PW
Erdman
Ruud A M
RA
van Domburg
Ron T
RT
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000523:psychology*; D001007:Anxiety / Q000453:epidemiology / Q000523:psychology*; D015897:Comorbidity; D003327:Coronary Disease / Q000145:classification / Q000453:epidemiology / Q000628:therapy*; D003866:Depressive Disorder / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology*; D018450:Disease Progression; D004644:Emotions; D005260:Female; D005500:Follow-Up Studies; D006304:Health Status; D006801:Humans; D008297:Male; D008603:Mental Health; D008875:Middle Aged; D015607:Stents; D013997:Time Factors